Carderock Capital Management Inc. Has $7.27 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Carderock Capital Management Inc. raised its stake in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 1.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 13,804 shares of the healthcare conglomerate’s stock after acquiring an additional 191 shares during the quarter. UnitedHealth Group comprises 2.0% of Carderock Capital Management Inc.’s holdings, making the stock its 26th largest position. Carderock Capital Management Inc.’s holdings in UnitedHealth Group were worth $7,267,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Moneta Group Investment Advisors LLC boosted its position in shares of UnitedHealth Group by 100,076.4% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock worth $6,268,753,000 after acquiring an additional 11,812,017 shares in the last quarter. Norges Bank acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $5,210,004,000. Arrowstreet Capital Limited Partnership boosted its position in shares of UnitedHealth Group by 1,682.4% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock worth $1,372,606,000 after acquiring an additional 2,540,538 shares in the last quarter. Barclays PLC boosted its position in UnitedHealth Group by 143.4% in the second quarter. Barclays PLC now owns 3,494,100 shares of the healthcare conglomerate’s stock valued at $1,679,401,000 after buying an additional 2,058,829 shares in the last quarter. Finally, Morgan Stanley boosted its position in UnitedHealth Group by 13.8% in the fourth quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock valued at $8,289,386,000 after buying an additional 1,893,192 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Trading Down 6.4 %

Shares of UNH opened at $458.16 on Wednesday. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.62. UnitedHealth Group Incorporated has a twelve month low of $445.68 and a twelve month high of $554.70. The stock has a market capitalization of $422.39 billion, a P/E ratio of 19.22, a PEG ratio of 1.33 and a beta of 0.54. The firm has a fifty day simple moving average of $500.89 and a two-hundred day simple moving average of $518.93.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.98 by $0.18. The company had revenue of $94.43 billion during the quarter, compared to analyst estimates of $92.13 billion. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. UnitedHealth Group’s quarterly revenue was up 14.1% compared to the same quarter last year. During the same period last year, the business earned $5.34 EPS. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 27.82 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were given a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.64%. UnitedHealth Group’s dividend payout ratio (DPR) is 31.54%.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on UNH shares. Stephens restated an “overweight” rating and issued a $605.00 target price on shares of UnitedHealth Group in a research report on Thursday, February 8th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a research note on Friday, January 19th. Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. HSBC reaffirmed a “reduce” rating and set a $480.00 price target (down previously from $550.00) on shares of UnitedHealth Group in a research note on Monday, December 18th. Finally, Oppenheimer reissued an “outperform” rating and set a $610.00 target price on shares of UnitedHealth Group in a research note on Wednesday, January 17th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $579.33.

View Our Latest Stock Report on UnitedHealth Group

Insider Activity at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by company insiders.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.